Resultados de búsqueda - Arlene A. Forastiere

Limitar resultados
  1. 1
    Controversies in Treatment Deintensification of Human Papillomavirus–Associated Oropharyngeal Carcinomas: Should We, How Should We, and for Whom?

    Controversies in Treatment Deintensification of Human Papillomavirus–Associated Oropharyngeal Carcinomas: Should We, How Should We, and for Whom? por Harry Quon, Arlene A. Forastiere

    Publicado 2013
    Enlace del recurso Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:
  2. 2
    Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck

    Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck por Athanassios Argiris, Yi Li, Arlene A. Forastiere

    Publicado 2004
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes

    Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes por Arlene A. Forastiere, Randal S. Weber, Andy Trotti

    Publicado 2015
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  4. 4
    HPV-associated head and neck cancer: a virus-related cancer epidemic

    HPV-associated head and neck cancer: a virus-related cancer epidemic por Shanthi Marur, Gypsyamber D’Souza, William H. Westra, Arlene A. Forastiere

    Publicado 2010
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  5. 5
    Head and Neck Cancer: Recent Advances and New Standards of Care

    Head and Neck Cancer: Recent Advances and New Standards of Care por Arlene A. Forastiere, Andy Trotti, David G. Pfister, Jennifer R. Grandis

    Publicado 2006
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    Outcome of Elderly Patients With Recurrent or Metastatic Head and Neck Cancer Treated With Cisplatin-Based Chemotherapy

    Outcome of Elderly Patients With Recurrent or Metastatic Head and Neck Cancer Treated With Cisplatin-Based Chemotherapy por Athanassios Argiris, Yi Li, Barbara A. Murphy, Corey J. Langer, Arlene A. Forastiere

    Publicado 2004
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of the Eastern Cooperative Oncology Group (E2382)

    Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of... por Harry Quon, Traci Leong, Robert E. Haselow, Bruce Leipzig, Jay S. Cooper, Arlene A. Forastiere

    Publicado 2010
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck

    A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck por Athanassios Argiris, Musie Ghebremichael, Barbara Burtness, Rita Axelrod, Ronald C. DeConti, Arlene A. Forastiere

    Publicado 2011
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region

    Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region por Tsung‐Teh Wu, Toshiaki Watanabe, Richard F. Heitmiller, Marianna Zahurak, Arlene A. Forastiere, Stanley R. Hamilton

    Publicado 1998
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma

    Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma por Mark B. Orringer, Arlene A. Forastiere, Claudia Perez-Tamayo, Susan G. Urba, Bonnie J. Takasugi, Judith Bromberg

    Publicado 1990
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  11. 11
    Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials

    Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials por Athanassios Argiris, S. Li, Musie Ghebremichael, Ann Marie Egloff, Ling Wang, Arlene A. Forastiere, Barbara Burtness, Ranee Mehra

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

    Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis por Mitchell Machtay, Jennifer Moughan, A. Trotti, Adam S. Garden, Randal S. Weber, Jay S. Cooper, Arlene A. Forastiere, K. Kian Ang

    Publicado 2008
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

    Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial por Athanassios Argiris, Musie Ghebremichael, Jill Gilbert, Ju-Whei Lee, Kamakshi Sachidanandam, Jill Kolesar, Barbara Burtness, Arlene A. Forastiere

    Publicado 2013
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy

    Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy por Antonio Jimeno, P. Kulesza, Jenna Wheelhouse, Andrew M. Chan, X Zhang, E Kincaid, Allen Chen, Douglas P. Clark, Arlene A. Forastiere, Manuel Hidalgo

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  15. 15
    Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients

    Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients por Amitabh Chak, Marcia I. Canto, Gregory S. Cooper, Gerard Isenberg, Joseph Willis, Nathan Levitan, Julie Clayman, Arlene A. Forastiere, Elisabeth I. Heath, Michael Sivak

    Publicado 2000
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  16. 16
    Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neck

    Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neck por Joseph Brennan, Jay O. Boyle, Wayne M. Koch, Steven N. Goodman, Ralph H. Hruban, Yolanda Eby, Marion Couch, Arlene A. Forastiere, David Sidransky

    Publicado 1995
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  17. 17
    Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14)

    Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-... por Adam S. Garden, Jonathan Harris, Andy Trotti, Christopher U. Jones, Luis A. Carrascosa, Jonathan D. Cheng, Sharon Spencer, Arlene A. Forastiere, Randal S. Weber, K. Kian Ang

    Publicado 2008
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology Group Study E2399

    Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology... por Anthony J. Cmelak, Sigui Li, Meredith A. Goldwasser, Barbara A. Murphy, Michael W. Cannon, Harlan Pinto, David I. Rosenthal, Maura L. Gillison, Arlene A. Forastiere

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  19. 19
    Hypopharyngeal Dose Is Associated With Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis

    Hypopharyngeal Dose Is Associated With Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis por Mitchell Machtay, Jennifer Moughan, Andrew Farach, Elizabeth Martin-O'Meara, James M. Galvin, Adam S. Garden, Randal S. Weber, Jay S. Cooper, Arlene A. Forastiere, K. Kian Ang

    Publicado 2012
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  20. 20
    Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14

    Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14 por K. Kian Ang, Jonathan Harris, Adam S. Garden, Andy Trotti, Christopher U. Jones, Luis A. Carrascosa, Jonathan D. Cheng, Sharon Spencer, Arlene A. Forastiere, Randal S. Weber

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: